Aeras is a nonprofit, global biotech advancing the development of new TB vaccines for the world, in partnership with other biotech, pharmaceutical and academic organizations. Serving as a critical translational bridge from the bench to the field, Aeras has sponsored and conducted over 30 clinical vaccine trials enrolling thousands of subjects, and is a key partner in several active clinical development programs.
You can also send us a message by using the Contact Us link.
The AerasSHARE development team would like to acknowledge the role of the National Heart, Lung, and Blood Institute and its BioLINCC Program in the approach used in the development of this website. The AerasSHARE code was based on the success of the BioLINCC framework, which shares many of the same advanced features and a well-defined yet flexible workflow for request submission and fulfillment.
Bioshare is developed and maintained by Information Management Services, Inc.